An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money – and lead to safer drugs reaching patients faster.

Source: Research Information Centre
A faster way to spot the tell-tale signs of cancer-causing drugs